​

DataMEDS AI Stock (NASDAQ:MEDS)

RevenueOwnershipFinancialsChart
DataMEDS AI by TradingView

Previous Close

$2.30

52W Range

$0.82 - $46.50

50D Avg

$2.40

200D Avg

$6.33

Market Cap

$10.02M

Avg Vol (3M)

$6.49M

Beta

-1.52

Div Yield

-

MEDS Company Profile

DataMEDS AI is a Health IT company focused on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units. The company incorporates its artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contacts platform PharmacyChain™ to optimize the prescription medicines reimbursement and dispensing journey.

Show More

Industry

Medical - Distribution

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

31

IPO Date

Feb 21, 2025

Website

MEDS Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24
Product$21.87M$17.67M

Fiscal year ends in Dec 25 | Currency in USD

MEDS Financial Summary

Dec 25Dec 24Dec 23
Revenue$23.34M$18.13M-
Operating Income$-81.19M$-6.15M$-2.88M
Net Income$-101.27M$-6.86M$-2.90M
EBITDA$-93.48M$-4.91M$-2.88M
Basic EPS$-71.50$-6.50$-3.00
Diluted EPS$-71.50$-6.50$-3.00

Fiscal year ends in Dec 25 | Currency in USD

Peer Comparison

TickerCompany
OKUROnKure Therapeutics, Inc.
ALGSAligos Therapeutics, Inc.
BEATHeartBeam, Inc.
BDSXBiodesix, Inc.
TELATELA Bio, Inc.
INMBINmune Bio, Inc.
XLOXilio Therapeutics, Inc.
MRSNMersana Therapeutics, Inc.